Welcome!

News Feed Item

Applied Biologics LLC Names Edward Britt President

SCOTTSDALE, Ariz., Feb. 6, 2014 /PRNewswire/ -- Applied Biologics LLC, an integrated biotechnology company engaged in the development and commercialization of innovative biologic products derived from the placental tissues, is pleased to announce the appointment of Edward Britt as President.

(Logo: http://photos.prnewswire.com/prnh/20140206/LA60748LOGO)

Since early 2013, Mr. Britt has been an active and engaged part of both the board and the Company. Britt continues his work with the Company as President effective January 15, 2014. As President, Britt will direct all facets of a robust integrated biotechnology companyincluding all development, development services, financing and distribution activities.

"I am honored to have been chosen by the board to lead Applied Biologics into the next exciting era of the Company," said Edward Britt. "Applied Biologics' focus on execution in research, supply chain management, and superior distribution channels has helped to establish us as a leader in placental tissue-derived products. I look forward to working with our executive team, our employees and distribution partners in driving growth for our Company and the entire regenerative medicine technology space."

"Applied Biologics' board of directors is responsible for ensuring the continuity of the Company's senior leadership and that the executive team possesses the experience, skills and character required to achieve the Company's goals. With today's announcement, we enable a smooth transition to a proven executive in Edward Britt, while providing for ongoing guidance and leadership from Jon and Jason, the co-founders. We have the highest degree of confidence that his leadership will further expand Applied Biologics' impressive record of innovation and commercialization of placental-derived products and continued shareholder value creation," said Ian Vasquez, Director of Operations.

Mr. Wakefield will continue to guide the Company's future strategies and direction. "I am very proud of what we have accomplished during my time as President, and speaking on behalf of the Company co-founders, we look forward to being part of the Company's continued success. At its heart, Applied Biologics is a company of innovators and entrepreneurs and I'm excited by the opportunities that lay ahead," Wakefield said. "I want to congratulate Edward on his new role. Having worked with him for the last year in the Company, I have the utmost confidence in Edward and in the rest of the management team that they will continue to drive technical and business innovations, ensuring the growth and future of Applied Biologics. I very much look forward to continuing to work with Edward in his role as President."

About Applied Biologics LLC
Applied Biologics LLC is a global leader in advancing regenerative medicine through the research, translational biotechnology, development and commercialization of placental-tissue derived products, including, but not limited to FloGraft® and XWRAP®. All of our allograft is procured from consenting donors through a scheduled, full-term Caesarean section birth without fetal sacrifice or harm. Amniotic membrane and fluid offer a rich source of native organic cellular components that deserve extensive research to explore their full potential. Immune privilege is a unique characteristic that differentiates this human allograft from other tissue sources. Applied Biologics is focused on optimizing the regenerative potential of this unique allograft. Since 2010, Applied Biologics has been an industry leader in providing innovative amnion-technology for management of soft-tissue defects, orthopedic procedures, sports medicine, chronic wounds, and nerve, ligament and tendon defects. For more information, please visit: www.appliedbiologics.com.

Applied Biologics Forward-looking Statement

This publication may include "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Applied Biologics' management and are subject to significant risks and uncertainties. Applied Biologics undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.Accordingly, all written or oral forward-looking statements attributable to Applied Biologics, LLC are qualified by this caution.

SOURCE Applied Biologics LLC

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that SD Times | BZ Media has been named “Media Sponsor” of SYS-CON's 20th International Cloud Expo, which will take place on June 6–8, 2017, at the Javits Center in New York City, NY. BZ Media LLC is a high-tech media company that produces technical conferences and expositions, and publishes a magazine, newsletters and websites in the software development, SharePoint, mobile development and commercial UAV markets.
SYS-CON Events announced today that Cloudistics, an on-premises cloud computing company, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloudistics delivers a complete public cloud experience with composable on-premises infrastructures to medium and large enterprises. Its software-defined technology natively converges network, storage, compute, virtualization, and management into a ...
Now that the world has connected “things,” we need to build these devices as truly intelligent in order to create instantaneous and precise results. This means you have to do as much of the processing at the point of entry as you can: at the edge. The killer use cases for IoT are becoming manifest through AI engines on edge devices. An autonomous car has this dual edge/cloud analytics model, producing precise, real-time results. In his session at @ThingsExpo, John Crupi, Vice President and Eng...
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., will discuss how these tools can be leveraged to develop a lasting competitive advanta...
SYS-CON Events announced today that HTBase will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. HTBase (Gartner 2016 Cool Vendor) delivers a Composable IT infrastructure solution architected for agility and increased efficiency. It turns compute, storage, and fabric into fluid pools of resources that are easily composed and re-composed to meet each application’s needs. With HTBase, companies can quickly prov...
There are 66 million network cameras capturing terabytes of data. How did factories in Japan improve physical security at the facilities and improve employee productivity? Edge Computing reduces possible kilobytes of data collected per second to only a few kilobytes of data transmitted to the public cloud every day. Data is aggregated and analyzed close to sensors so only intelligent results need to be transmitted to the cloud. Non-essential data is recycled to optimize storage.
"I think that everyone recognizes that for IoT to really realize its full potential and value that it is about creating ecosystems and marketplaces and that no single vendor is able to support what is required," explained Esmeralda Swartz, VP, Marketing Enterprise and Cloud at Ericsson, in this SYS-CON.tv interview at @ThingsExpo, held June 7-9, 2016, at the Javits Center in New York City, NY.
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
While DevOps most critically and famously fosters collaboration, communication, and integration through cultural change, culture is more of an output than an input. In order to actively drive cultural evolution, organizations must make substantial organizational and process changes, and adopt new technologies, to encourage a DevOps culture. Moderated by Andi Mann, panelists discussed how to balance these three pillars of DevOps, where to focus attention (and resources), where organizations might...
SYS-CON Events announced today that IoT Now has been named “Media Sponsor” of SYS-CON's 20th International Cloud Expo, which will take place on June 6–8, 2017, at the Javits Center in New York City, NY. IoT Now explores the evolving opportunities and challenges facing CSPs, and it passes on some lessons learned from those who have taken the first steps in next-gen IoT services.
In their Live Hack” presentation at 17th Cloud Expo, Stephen Coty and Paul Fletcher, Chief Security Evangelists at Alert Logic, provided the audience with a chance to see a live demonstration of the common tools cyber attackers use to attack cloud and traditional IT systems. This “Live Hack” used open source attack tools that are free and available for download by anybody. Attendees learned where to find and how to operate these tools for the purpose of testing their own IT infrastructure. The...
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex softw...
Information technology (IT) advances are transforming the way we innovate in business, thereby disrupting the old guard and their predictable status-quo. It’s creating global market turbulence. Industries are converging, and new opportunities and threats are emerging, like never before. So, how are savvy chief information officers (CIOs) leading this transition? Back in 2015, the IBM Institute for Business Value conducted a market study that included the findings from over 1,800 CIO interviews ...
Virtualization over the past years has become a key strategy for IT to acquire multi-tenancy, increase utilization, develop elasticity and improve security. And virtual machines (VMs) are quickly becoming a main vehicle for developing and deploying applications. The introduction of containers seems to be bringing another and perhaps overlapped solution for achieving the same above-mentioned benefits. Are a container and a virtual machine fundamentally the same or different? And how? Is one techn...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.